Clear Cell Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Clear Cell Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 study of bevacizumab, erlotinib, and imatinib in advanced clear cell renal cell carcinoma has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in patients undergoing surgery for metastatic kidney cancer was terminated; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Vandetanib to Treat Advanced Kidney Cancer [Phase 2]
Phase 2 study of Vandetanib for advanced Clear cell renal cell carcinoma was terminated; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC) [Phase 2]
This document describes a Phase 2 trial evaluating neoadjuvant sunitinib for metastatic clear cell renal cell carcinoma; the current status …
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial of GW786034 in locally recurrent or metastatic clear cell renal cell carcinoma has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.